Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Official Register
None
House documents
None
Ultimate John Fitzpatrick Group C Porsches
From 1983 to 1986, Fitzpatrick's operation made 66 Group C entries in 44 races in the World Endurance Championship, the German Deutsche Rennsport-Meisterschaft and the American Can-Am, winning three times and taking another 11 podium positions. This book tells the story of this exciting team, its five Group C Porsches and what became of them, its crews, its drivers, its races and - above all - its charismatic owner, John Fitzpatrick, arguably the best British driver never to have raced in Formula 1.
Housing and Social Policy
This book is part of a series called "Studies in Social Policy", and looks at housing in the context of a social policy. The book explores such issues as homelessness, housing disadvantage, assistance with housing costs, and housing and community care for older people.
Psychological Interventions for Psychosis
This book shows how psychological and social interventions can help people with psychosis. It brings together both theoretical chapters that contribute to the reconceptualization of psychosis and clinical cases illustrating how contemporary psychotherapeutic intervention models can be applied in the treatment of this mental health condition, with reflections, strategies and practical guidelines demonstrating how these models can inform professional practice in mental healthcare. Chapters brought together in this volume aim to reflect a paradigm shift in psychosis care. They present person-centered models that lead to a way of seeing, understanding and treating psychosis that is very differen...
Advances in Eicosanoid Research
Over the last few years, we have witnessed tremendous progress in the field of eicosanoids and their therapeutic applications. Receptor an tagonists for leukotrienes have been tested as anti-inflammatories and are on the market as a treatment for asthma. Receptor agonists for pro stacyclin are being tested for the treatment of peripheral vascular dis ease, and selective inhibitors of cyclooxygenase type II were just ap proved for the treatment of rheumatoid arthritis. All these developments are the culmination of many years and man-hours of careful research. The field has now entered an upswing that will result in novel thera peutic applications within the next 10 years. New molecules and me diators have been identified, new enzymes and pathways elucidated and new therapeutic approaches have emerged. The concept of ei cosanoids as "pro-inflammatory" molecules is being challenged, and their role as regulators is increasingly recognized. In fact, some of these molecules may be important endogenous anti-inflammatory agents.
